 22. Treatment with medications known to be sensitive CYP3A4 substrates with a narrow therapeutic index e.g. alfentanil, astemizole, cisapride, cyclosporine, diergotamine, ergotamine, fentanyl, pimozide, quinidine, sirolimus, tacrolimus, terfenadine within 7 days prior to Day 1 visit. 